About Spiral Therapeutics
Spiral Therapeutics is a company based in Brisbane (United States) founded in 2016.. Spiral Therapeutics has raised $47.2 million across 5 funding rounds from investors including Esperante, Catalio Capital Management and Humboldt Fund. Spiral Therapeutics offers products and services including SPT-2101 and MICS Platform. Spiral Therapeutics operates in a competitive market with competitors including Lyra Therapeutics, Decibel Therapeutics, Perceive Bio, Akouos and Auris Medical, among others.
- Headquarter Brisbane, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Spiral Therapeutics, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$47.2 M (USD)
in 5 rounds
-
Latest Funding Round
$27 M (USD), Series B
Apr 14, 2026
-
Investors
Esperante
& 7 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Spiral Therapeutics
Spiral Therapeutics offers a comprehensive portfolio of products and services, including SPT-2101 and MICS Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Sustained-release steroid for treating Ménière’s disease effectively.
Minimally invasive system for precise and durable drug exposure in the ear.
Unlock access to complete
Unlock access to complete
Funding Insights of Spiral Therapeutics
Spiral Therapeutics has successfully raised a total of $47.2M across 5 strategic funding rounds. The most recent funding activity was a Series B round of $27 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Series B — $27.0M
-
First Round
First Round
(18 Dec 2018)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2026 | Amount | Series B - Spiral Therapeutics | Valuation | Gund investment |
|
| Aug, 2023 | Amount | Series B - Spiral Therapeutics | Valuation | Esperante |
|
| Feb, 2023 | Amount | Series B - Spiral Therapeutics | Valuation | Catalio Capital Management , Humboldt Fund |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Spiral Therapeutics
Spiral Therapeutics has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Esperante, Catalio Capital Management and Humboldt Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Esperante is focused on innovative life science investments.
|
Founded Year | Domain | Location | |
|
Venture capital is provided to biomedical technology startups.
|
Founded Year | Domain | Location | |
|
Early-stage companies in science and technology are supported by Humboldt Fund.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Spiral Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Spiral Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Spiral Therapeutics Comparisons
Competitors of Spiral Therapeutics
Spiral Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Lyra Therapeutics, Decibel Therapeutics, Perceive Bio, Akouos and Auris Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Small molecule therapeutics for ENT diseases are developed.
|
|
| domain | founded_year | HQ Location |
Medicines are developed to protect, repair, and restore hearing capacity.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics to treat diabetes and eye diseases
|
|
| domain | founded_year | HQ Location |
Developer of gene therapies to restore and preserve hearing capabilities in genetically defined populations
|
|
| domain | founded_year | HQ Location |
Speciality Pharma company developing novel therapies for inner ear disorders
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Spiral Therapeutics
Frequently Asked Questions about Spiral Therapeutics
When was Spiral Therapeutics founded?
Spiral Therapeutics was founded in 2016 and raised its 1st funding round 2 years after it was founded.
Where is Spiral Therapeutics located?
Spiral Therapeutics is headquartered in Brisbane, United States. It is registered at Brisbane, California, United States.
Is Spiral Therapeutics a funded company?
Spiral Therapeutics is a funded company, having raised a total of $47.2M across 5 funding rounds to date. The company's 1st funding round was a Series B of $10.9M, raised on Dec 18, 2018.
What does Spiral Therapeutics do?
Spiral Therapeutics was founded in 2016 and is headquartered in Brisbane, United States. Therapeutics targeting balance disorders and hearing loss are developed by the company within the biotechnology sector. A pipeline is advanced, with the lead program SPT-2101 consisting of a sustained-release steroid formulation for Ménières disease treatment. Operations focus on inner ear conditions through pharmaceutical innovation.
Who are the top competitors of Spiral Therapeutics?
Spiral Therapeutics's top competitors include Decibel Therapeutics, Lyra Therapeutics and Akouos.
What products or services does Spiral Therapeutics offer?
Spiral Therapeutics offers SPT-2101 and MICS Platform.
Who are Spiral Therapeutics's investors?
Spiral Therapeutics has 8 investors. Key investors include Esperante, Catalio Capital Management, Humboldt Fund, Prévigesst, and Sunghwan Choi.